AKR 31.99 Acadia Realty Trust $AKR Hit a 52 week high of 32.33 Closing the day 11/04/14 at 31.99 -0.15 -0.47% With a day low of 31.82 and a total volume of 424,300.
AKR Recent Posts: http://investorshangout.com/Acadia-Realty-Trust-AKR-50067/
AKR Acadia Realty Trust Recent Headline News
Acadia Realty Trust Announces Closing of Common Share Offering
Business Wire - Tue Nov 04, 10:46AM CST
Acadia Realty Trust (NYSE:AKR) (the "Company"
announced today the completion of its previously announced public offering of 3,400,000 common shares of beneficial interest ("Shares" , as well as the underwriters' full exercise of their option to purchase an additional 510,000 Shares, bringing the total issuance to 3,910,000 Shares. The Company received gross proceeds of approximately $116.3 million before accounting for underwriting discounts and estimated offering expenses.
AKR: 31.99 (-0.15)
NYSE stocks posting largest volume increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
CALX: 10.99 (+0.15), AVP: 10.20 (-0.42), RCAP: 10.91 (-2.78), ORB: 25.12 (-0.57), MPLX: 68.00 (-2.00), CCO: 7.16 (-0.10), NKA: 5.66 (-0.21), UBA: 22.00 (unch), AKR: 31.99 (-0.15), ACCO: 8.41 (+0.08), WNC: 10.30 (+0.16), FCN: 40.98 (-0.01), UBP: 18.41 (-0.19), MWA: 9.61 (-0.06)
Acadia Realty Trust Announces Pricing of 3.4 Million Common Share Offering
Business Wire - Thu Oct 30, 8:03AM CDT
Acadia Realty Trust (NYSE:AKR - "Acadia" or the "Company" today announced that it expects to receive approximately $101.2 million in estimated gross proceeds from its sale of 3,400,000 common shares of beneficial interest ("Shares" to BofA Merrill Lynch and Barclays (or approximately $116.3 million if the option to purchase additional Shares is exercised in full). BofA Merrill Lynch and Barclays acted as joint bookrunners for the offering. The Company has also granted the underwriters an option to purchase up to 510,000 additional Shares. The offering was made pursuant to the Company's effective shelf registration statement and settlement is expected to occur on or about November 4, 2014.
AKR: 31.99 (-0.15)
Acadia Realty Trust Announces Sale of 3.4 Million Common Shares
Business Wire - Wed Oct 29, 3:02PM CDT
Acadia Realty Trust (NYSE:AKR)("Acadia" or the "Company" today announced the sale of 3,400,000 common shares of beneficial interest of the Company ("Shares" to BofA Merrill Lynch and Barclays, in a public offering pursuant to the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission. The Company has also granted the underwriters an option to purchase up to 510,000 additional Shares.
AKR: 31.99 (-0.15)
Acadia Realty Trust reports 3Q results
Automated Insights - Tue Oct 28, 6:42PM CDT
WHITE PLAINS, N.Y. (AP) _ Acadia Realty Trust (AKR) on Tuesday reported a key measure of profitability in its third quarter. The results did not meet Wall Street expectations.
AKR: 31.99 (-0.15)
Acadia Realty Trust Reports Third Quarter 2014 Operating Results
Business Wire - Tue Oct 28, 3:05PM CDT
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended September 30, 2014. Acadia operates a dual platform strategy comprised of a high-quality portfolio with concentrations of assets in the nation's most dynamic street-retail corridors ("Core Portfolio" and opportunistic and value-add investments through a series of discretionary institutional funds ("Funds" . All per share amounts below are on a fully diluted basis.
AKR: 31.99 (-0.15)
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers" , a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement" with Hainan Savy Investment Management Ltd ("Hainan" and Mr. Thomas Knox ("Thomas Knox" , the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties" , to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture" . The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd.
AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
Acadia Realty Trust to Participate at BMO Capital Markets 9th Annual North American Real Estate Conference
Business Wire - Fri Sep 12, 1:57PM CDT
Acadia Realty Trust (NYSE:AKR) today announced it is scheduled to participate at the BMO Capital Markets 9th Annual North American Real Estate Conference, which will be held on September 15th and 16th, 2014 in Chicago. Acadia will be engaging in individual meetings with investors at the conference. Company information to be presented in these meetings will be posted to the Company's website under "Investor Relations - Presentations - September 2014 Corporate Snapshot."
AKR: 31.99 (-0.15)
Acadia Realty Trust Provides Update on $392 Million of Transactions
Business Wire - Mon Sep 08, 4:56PM CDT
Acadia Realty Trust (NYSE:AKR) today announced that it has completed both the previously-reported sale of six retail properties in Miami Beach, Florida owned by its fund platform and the acquisition of a retail property in Manhattan's Soho submarket on behalf of its core portfolio.
AKR: 31.99 (-0.15)
Acadia Realty Trust to Announce Third Quarter 2014 Earnings on October 28, 2014
Business Wire - Wed Sep 03, 3:58PM CDT
Acadia Realty Trust (NYSE:AKR), will release its third quarter 2014 earnings on Tuesday, October 28, 2014 after market close. The Company will conduct a conference call the following day, Wednesday, October 29, 2014 at 12:00 PM ET to discuss its quarterly results.
AKR: 31.99 (-0.15)
Acadia Realty Trust Up 10.2% Since SmarTrend Uptrend Call (AKR)
Comtex SmarTrend(R) - Tue Aug 19, 9:29AM CDT
SmarTrend identified an Uptrend for Acadia Realty Trust (NYSE:AKR) on February 14th, 2014 at $26.32. In approximately 6 months, Acadia Realty Trust has returned 10.18% as of today's recent price of $29.00.
AKR: 31.99 (-0.15)
Acadia Realty Trust to Participate at Bank of America Merrill Lynch Global Real Estate Conference
Business Wire - Thu Aug 14, 10:28AM CDT
Acadia Realty Trust (NYSE:AKR) today announced it is scheduled to participate at the Bank of America Merrill Lynch 2014 Global Real Estate Conference, which will be held on September 10th and 11th, 2014 in New York City.
AKR: 31.99 (-0.15)
Acadia Realty Trust declares dividend of USD0.23 per share for quarter
M2 - Thu Aug 07, 7:03AM CDT
The board of trustees of real estate investment trust Acadia Realty Trust (NYSE:AKR) approved a common stock cash dividend of USD0.23 per share for the quarter ending 30 September 2014, the company declared on Thursday.
AKR: 31.99 (-0.15)
Acadia Realty Trust Announces Quarterly Dividend
Business Wire - Wed Aug 06, 3:06PM CDT
Acadia Realty Trust (NYSE:AKR), today announced the Company's dividend for the quarter ending September 30, 2014. Acadia's Board of Trustees has declared a cash dividend of $0.23 per Common Share payable on October 15, 2014 to holders of record as of September 30, 2014.
AKR: 31.99 (-0.15)
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers" , a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Nicolas Daurel as Vice President of International Sales and Marketing for Europe, the Middle East and Africa ("EMEA" . Mr. Daurel has a twenty year track-record of successfully building and managing the sales of medical devices in EMEA, particularly within the coagulation sector.
AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
Acadia Realty Trust Reports Second Quarter 2014 Operating Results
Business Wire - Tue Jul 29, 3:05PM CDT
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended June 30, 2014. Acadia operates a dual platform strategy comprised of a high-quality portfolio with concentrations of assets in the nation's most dynamic street-retail corridors ("Core Portfolio" and opportunistic and value-add investments through a series of discretionary institutional funds ("Funds" . All per share amounts below are on a fully diluted basis.
AKR: 31.99 (-0.15)
General Growth Properties Q2 FFO In Line, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 9:40AM CDT
General Growth Properties (GGP) reported second-quarter 2014 FFO per share of 31 cents, which came in line with the Zacks Consensus Estimate but improved from the year-ago quarter figure by 4 cents.
GGP: 26.38 (-0.02), DDR: 18.41 (+0.07), O: 47.63 (+0.70), AKR: 31.99 (-0.15)
EPR Properties (EPR) Crumbles: Stock Tumbles 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:50AM CDT
EPR Properties saw a big move last session, as the company’s shares fell by over 9% on the day.
GGP: 26.38 (-0.02), O: 47.63 (+0.70), AKR: 31.99 (-0.15), EPR: 56.84 (-0.02)
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers" , a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta" to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year.
AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
EPR Properties (EPR) Jumps: Stock Rises 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:57AM CDT
EPR Properties (EPR) was a big mover last session, as the company saw its shares rise over 6% on the day.
GGP: 26.38 (-0.02), AKR: 31.99 (-0.15), MAC: 71.33 (+0.05), EPR: 56.84 (-0.02)
AKR Recent Posts: http://investorshangout.com/Acadia-Realty-Trust-AKR-50067/
AKR Acadia Realty Trust Recent Headline News
Acadia Realty Trust Announces Closing of Common Share Offering
Business Wire - Tue Nov 04, 10:46AM CST
Acadia Realty Trust (NYSE:AKR) (the "Company"
announced today the completion of its previously announced public offering of 3,400,000 common shares of beneficial interest ("Shares" , as well as the underwriters' full exercise of their option to purchase an additional 510,000 Shares, bringing the total issuance to 3,910,000 Shares. The Company received gross proceeds of approximately $116.3 million before accounting for underwriting discounts and estimated offering expenses. AKR: 31.99 (-0.15)
NYSE stocks posting largest volume increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
CALX: 10.99 (+0.15), AVP: 10.20 (-0.42), RCAP: 10.91 (-2.78), ORB: 25.12 (-0.57), MPLX: 68.00 (-2.00), CCO: 7.16 (-0.10), NKA: 5.66 (-0.21), UBA: 22.00 (unch), AKR: 31.99 (-0.15), ACCO: 8.41 (+0.08), WNC: 10.30 (+0.16), FCN: 40.98 (-0.01), UBP: 18.41 (-0.19), MWA: 9.61 (-0.06)
Acadia Realty Trust Announces Pricing of 3.4 Million Common Share Offering
Business Wire - Thu Oct 30, 8:03AM CDT
Acadia Realty Trust (NYSE:AKR - "Acadia" or the "Company"
today announced that it expects to receive approximately $101.2 million in estimated gross proceeds from its sale of 3,400,000 common shares of beneficial interest ("Shares" to BofA Merrill Lynch and Barclays (or approximately $116.3 million if the option to purchase additional Shares is exercised in full). BofA Merrill Lynch and Barclays acted as joint bookrunners for the offering. The Company has also granted the underwriters an option to purchase up to 510,000 additional Shares. The offering was made pursuant to the Company's effective shelf registration statement and settlement is expected to occur on or about November 4, 2014. AKR: 31.99 (-0.15)
Acadia Realty Trust Announces Sale of 3.4 Million Common Shares
Business Wire - Wed Oct 29, 3:02PM CDT
Acadia Realty Trust (NYSE:AKR)("Acadia" or the "Company"
today announced the sale of 3,400,000 common shares of beneficial interest of the Company ("Shares" to BofA Merrill Lynch and Barclays, in a public offering pursuant to the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission. The Company has also granted the underwriters an option to purchase up to 510,000 additional Shares. AKR: 31.99 (-0.15)
Acadia Realty Trust reports 3Q results
Automated Insights - Tue Oct 28, 6:42PM CDT
WHITE PLAINS, N.Y. (AP) _ Acadia Realty Trust (AKR) on Tuesday reported a key measure of profitability in its third quarter. The results did not meet Wall Street expectations.
AKR: 31.99 (-0.15)
Acadia Realty Trust Reports Third Quarter 2014 Operating Results
Business Wire - Tue Oct 28, 3:05PM CDT
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended September 30, 2014. Acadia operates a dual platform strategy comprised of a high-quality portfolio with concentrations of assets in the nation's most dynamic street-retail corridors ("Core Portfolio"
and opportunistic and value-add investments through a series of discretionary institutional funds ("Funds" . All per share amounts below are on a fully diluted basis. AKR: 31.99 (-0.15)
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement" with Hainan Savy Investment Management Ltd ("Hainan" and Mr. Thomas Knox ("Thomas Knox" , the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties" , to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture" . The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd. AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
Acadia Realty Trust to Participate at BMO Capital Markets 9th Annual North American Real Estate Conference
Business Wire - Fri Sep 12, 1:57PM CDT
Acadia Realty Trust (NYSE:AKR) today announced it is scheduled to participate at the BMO Capital Markets 9th Annual North American Real Estate Conference, which will be held on September 15th and 16th, 2014 in Chicago. Acadia will be engaging in individual meetings with investors at the conference. Company information to be presented in these meetings will be posted to the Company's website under "Investor Relations - Presentations - September 2014 Corporate Snapshot."
AKR: 31.99 (-0.15)
Acadia Realty Trust Provides Update on $392 Million of Transactions
Business Wire - Mon Sep 08, 4:56PM CDT
Acadia Realty Trust (NYSE:AKR) today announced that it has completed both the previously-reported sale of six retail properties in Miami Beach, Florida owned by its fund platform and the acquisition of a retail property in Manhattan's Soho submarket on behalf of its core portfolio.
AKR: 31.99 (-0.15)
Acadia Realty Trust to Announce Third Quarter 2014 Earnings on October 28, 2014
Business Wire - Wed Sep 03, 3:58PM CDT
Acadia Realty Trust (NYSE:AKR), will release its third quarter 2014 earnings on Tuesday, October 28, 2014 after market close. The Company will conduct a conference call the following day, Wednesday, October 29, 2014 at 12:00 PM ET to discuss its quarterly results.
AKR: 31.99 (-0.15)
Acadia Realty Trust Up 10.2% Since SmarTrend Uptrend Call (AKR)
Comtex SmarTrend(R) - Tue Aug 19, 9:29AM CDT
SmarTrend identified an Uptrend for Acadia Realty Trust (NYSE:AKR) on February 14th, 2014 at $26.32. In approximately 6 months, Acadia Realty Trust has returned 10.18% as of today's recent price of $29.00.
AKR: 31.99 (-0.15)
Acadia Realty Trust to Participate at Bank of America Merrill Lynch Global Real Estate Conference
Business Wire - Thu Aug 14, 10:28AM CDT
Acadia Realty Trust (NYSE:AKR) today announced it is scheduled to participate at the Bank of America Merrill Lynch 2014 Global Real Estate Conference, which will be held on September 10th and 11th, 2014 in New York City.
AKR: 31.99 (-0.15)
Acadia Realty Trust declares dividend of USD0.23 per share for quarter
M2 - Thu Aug 07, 7:03AM CDT
The board of trustees of real estate investment trust Acadia Realty Trust (NYSE:AKR) approved a common stock cash dividend of USD0.23 per share for the quarter ending 30 September 2014, the company declared on Thursday.
AKR: 31.99 (-0.15)
Acadia Realty Trust Announces Quarterly Dividend
Business Wire - Wed Aug 06, 3:06PM CDT
Acadia Realty Trust (NYSE:AKR), today announced the Company's dividend for the quarter ending September 30, 2014. Acadia's Board of Trustees has declared a cash dividend of $0.23 per Common Share payable on October 15, 2014 to holders of record as of September 30, 2014.
AKR: 31.99 (-0.15)
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Nicolas Daurel as Vice President of International Sales and Marketing for Europe, the Middle East and Africa ("EMEA" . Mr. Daurel has a twenty year track-record of successfully building and managing the sales of medical devices in EMEA, particularly within the coagulation sector. AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
Acadia Realty Trust Reports Second Quarter 2014 Operating Results
Business Wire - Tue Jul 29, 3:05PM CDT
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended June 30, 2014. Acadia operates a dual platform strategy comprised of a high-quality portfolio with concentrations of assets in the nation's most dynamic street-retail corridors ("Core Portfolio"
and opportunistic and value-add investments through a series of discretionary institutional funds ("Funds" . All per share amounts below are on a fully diluted basis. AKR: 31.99 (-0.15)
General Growth Properties Q2 FFO In Line, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 9:40AM CDT
General Growth Properties (GGP) reported second-quarter 2014 FFO per share of 31 cents, which came in line with the Zacks Consensus Estimate but improved from the year-ago quarter figure by 4 cents.
GGP: 26.38 (-0.02), DDR: 18.41 (+0.07), O: 47.63 (+0.70), AKR: 31.99 (-0.15)
EPR Properties (EPR) Crumbles: Stock Tumbles 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:50AM CDT
EPR Properties saw a big move last session, as the company’s shares fell by over 9% on the day.
GGP: 26.38 (-0.02), O: 47.63 (+0.70), AKR: 31.99 (-0.15), EPR: 56.84 (-0.02)
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta" to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year. AKER: 3.37 (+0.05), AKR: 31.99 (-0.15)
EPR Properties (EPR) Jumps: Stock Rises 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:57AM CDT
EPR Properties (EPR) was a big mover last session, as the company saw its shares rise over 6% on the day.
GGP: 26.38 (-0.02), AKR: 31.99 (-0.15), MAC: 71.33 (+0.05), EPR: 56.84 (-0.02)
